Global expansion Genpact Pharmalink is expanding its Global Capability Center in Hyderabad, India, signaling a strong investment in AI, process transformation, and regulatory affairs services. This creates opportunities to offer complementary regulatory automation, compliance analytics, and cross-border life sciences process optimization to Nestlé and other global clients moving to GCC models.

Strategic partnerships The collaboration with Nestlé Business Solutions positions Genpact Pharmalink as a preferred partner for large enterprises adopting shared services and AI-driven regulatory and lifecycle management. Sales opportunities exist to replicate or expand similar GCC arrangements with other top-tier life sciences brands seeking efficiency, speed to market, and regulatory compliance.

Regulatory efficiency With focus on reducing time-to-market and ensuring compliance across developed and emerging markets, there is a clear demand for automation, AI-assisted regulatory affairs, and data-driven compliance monitoring. Upsell potential includes AI tooling, RPA workflows, and secure data platforms for regulatory submissions and sponsor-agnostic health authority interactions.

AI and data tooling Genpact Pharmalink’s tech stack includes AI and data tools (GPT-3, NLTK, Weaviate) and cloud/backups (AWS) which can be leveraged to offer advanced annotation, document classification, and regulatory information retrieval for life sciences. Opportunities exist to market AI-enabled regulatory intelligence, deduction management automation, and secure collaboration environments to peers and competitors.

Industry positioning Recognition as a leader in life and retirement BPO and its emphasis on AI-driven transformation positions Genpact Pharmalink to engage with other top life sciences firms seeking similar capabilities. Target potential clients within peers of ISG Leaders panel and comparable mid-to-large pharma/biotech players looking to-scale regulatory operations and accelerate product launches.